Sanjay Raj
University Hospital Southampton NHS Foundation Trust(GB)Hampshire Hospitals NHS Foundation Trust(GB)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, HER2/EGFR in Cancer Research, BRCA gene mutations in cancer, Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis
Most-Cited Works
- → 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial(2019)278 cited
- → The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer(2024)41 cited
- Evaluation of the efficacy of probiotics in plaque reduction and gingival health maintenance among school children - A Randomized Control Trial.(2013)
- → Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial(2025)10 cited
- → Abstract CT012: PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC)(2024)1 cited